The Daily Mail called ocrelizumab, “A Huge Breakthrough Drug” for Progressive Multiple Sclerosis, adding the claim it was a “game changer.” Where have I heard that before? When Biogen was ready to turn Antigren loose on the market, their PR machine went to work and elevated patient expectations to dizzying heights. Antigren became Tysabri, knocked off a few MS patients and was yanked off the market. Tysabri was then allowed back with no fix, only a bolder warning.
I do not believe anything I read in the popular press about new wonder drugs. I asked a few MS docs about Ocrelizumab and was told it is basically Rituximab. I did a few rounds of that drug with no result. Why would I have high hopes for the new stuff, especially when I have SPMS, not the real target, PPMS? The press lumps all progressive M together.
The trial results did sound promising. Patients with PPMS need hope and have been surviving in their no-therapy ghetto for too long. I wish them well. I just worry about news-hype. Too often newspapers are sold with stories that overstate. If a drug sounds too good to be true, Maybe it is.